Skip to main content
Equibles

PRICE T ROWE ASSOCIATES INC /MD/

Position in EBS — Emergent BioSolutions Inc.

CIK 80255 BALTIMORE, MD
Back to EBS Full portfolio

Position in EBS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$398,452
+$46,640 QoQ
Shares Held
47,548
+12.2% QoQ
Ownership
0.093%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#76
of 194 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in EBS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

PRICE T ROWE ASSOCIATES INC /MD/ holds $2,378,351,093 across 40 Drug Manufacturers - Specialty & Generic names. EBS ranks #32 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VTRS
Viatris Inc
 68,214,436 $1,083,245,243
2 ALKS
Alkermes plc.
 6,737,328 $353,035,986
3 LNTH
Lantheus Holdings, Inc.
 1,903,354 $211,158,092
4 LQDA
Liquidia Corp
 1,940,364 $154,705,221
5 UTHR
UNITED THERAPEUTICS Corp
 243,444 $131,905,262
6 PRGO
PERRIGO Co plc
 8,700,421 $90,397,373
7 ZTS
Zoetis Inc.
 1,139,097 $81,855,510
8 TEVA
Teva Pharmaceutical Industries Ltd
 1,679,152 $56,889,668

All Filings in EBS

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $398,452 47,548
2026-03-31 $351,812 42,387
2025-12-31 $481,829 38,983
2025-09-30 $356,689 40,441
2025-06-30 $247,716 38,827
2025-03-31 $57,348 11,800
2024-12-31 $112,808 11,800
2024-09-30 $98,530 11,800
2024-03-31 $60,575 23,943
2023-12-31 $46,881 19,534
2023-09-30 $61,863 18,195
2023-06-30 $203,521 27,690
2023-03-31 $244,817 23,631
2022-12-31 $268,287 22,717
2022-09-30 $590,637 28,139
2022-06-30 $4,126,054 132,927
2022-03-31 $10,334,350 251,689
2021-12-31 $11,827,013 272,073
2021-09-30 $27,065,288 540,549
2021-06-30 $34,898,727 554,036
2021-03-31 $72,010,267 775,054
2020-12-31 $78,164,083 872,367
2020-09-30 $91,526,717 885,771
2020-06-30 $69,147,710 874,402
2020-03-31 $51,123,360 883,570